Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Bès, Cédrica | Cerutti, Martinec | Briant-Longuet, Laurenceb | Bresson, Damiena | Peraldi-Roux, Sylviea | Pugnière, Martinea | Mani, Jean-Claudea | Pau, Bernarda | Devaux, Christianb | Granier, Claudea | Devauchelle, Gérardc | Chardès, Thierryc; *
Affiliations: [a] CNRS UMR 5094, Faculté de Pharmacie, 15 Avenue Charles Flahault, 34060 Montpellier, France | [b] CNRS EP 2104, Institut de Biologie, 34060 Montpellier, France | [c] INRA-CNRS UMR 5087, Laboratoire de Pathologie Comparée, 30380 Saint-Christol-Lez-Alès, France
Correspondence: [*] Corresponding author. Tel.: +33 4 67 548 604; Fax: +33 4 67 548 610; E-mail: chardes@pharma.univ-montp1.fr.
Abstract: The anti-CD4 mAb 13B8.2, directed against the CDR3-like loop of the D1 domain of CD4, inhibits signal transduction pathways leading to both T cell activation and HIV replication. VH9/DSP2/JH2 andκ12-13/Jκ2 rearrangements, corresponding to genes encoding the heavy and light chain variable regions of the 13B8.2 mAb, were inserted into baculovirus cassettes upstream from pre-installed human Fdγ1 and κ genes, respectively. After expression in insect cells, a complete correctly-processed Fab was secreted into the culture medium; it was protein-G immunopurified with a yield of 5 mg/L. The chimeric Fab 13B8.2 showed anti-CD4 binding activity with an affinity value of 3.3 nM and recognized the same region on the CDR3-like loop as the parental mAb. The mouse-human Fab inhibited IL2 secretion following antigen presentation and displayed a strong capacity to prevent HIV-1 promoter activation. Taken together, these results indicate that the chimeric Fab retained a major part of the parental 13B8.2 mAb properties and suggest that it might be a valuable therapeutic tool.
DOI: 10.3233/HAB-2001-10203
Journal: Human Antibodies, vol. 10, no. 2, pp. 67-76, 2001
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl